Deciduous Therapeutics
PrivateLast Round
VC Round
Mar 1, 2023
Est. Valuation
$45M
Total Funding Raised
$16.35M
Company Overview
Deciduous Therapeutics is a biotechnology company developing novel immunotherapies that activate the endogenous immune mechanism to selectively eliminate senescent cells for the treatment of age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deciduous Therapeutics Comparables
Compare Deciduous Therapeutics with similar companies based on industry and business-model similarity.
Deciduous Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 1, 2023 | ||||
| Series A | Dec 1, 2022 | ||||
| Grant | Oct 21, 2021 | ||||
| Seed | Jul 10, 2019 | ||||
| Accelerator | Mar 1, 2019 |
Deciduous Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | VC Round |
| Bakar Labs | Grant |
| Owl Capital | Series A |
| Gaingels | VC Round |
| age1 | Seed, Accelerator |
| Eisai Innovation | Grant |
| Presight Capital | Seed |
Deciduous Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Deciduous Therapeutics's valuation, stock price, and market status.